Table 4

Processes of Care Quality Measures Met During Hospitalization Stratified by NICM Etiology

NICM Etiologyp Value
Hypertension
(n = 28,141)
Idiopathic
(n = 17,808)
Other
(n = 7,523)
Substance Abuse
(n = 2,653)
Chemotherapy
(n = 721)
Familial
(n = 556)
Viral
(n = 447)
Post-Partum
(n = 209)
Achievement measures
 Discharged with appropriate instruction20,288 (91)12,043 (88)5,239 (90)2,237 (93)554 (92)438 (89)367 (93)196 (95)<0.001
 LV function documented25,457 (97)15,649 (97)6,553 (97)2,497 (99)632 (98)512 (98)415 (99)206 (100)<0.001
 Patients with LVSD discharged on ACEI/ARB7,551 (93)5,357 (92)1,975 (93)1,561 (95)288 (91)205 (95)270 (96)153 (96)<0.001
 Patients with LVSD discharged on beta-blockers8,478 (94)2,244 (95)5,823 (93)1,641 (96)351 (96)217 (95)288 (96)159 (98)<0.001
 Smokers discharged with smoking cessation counseling4,140 (96)2,654 (96)1,009 (96)1,559 (97)101 (100)121 (93)130 (97)75 (100)0.01
Composite performance measures
 100% defect-free care22,965 (86)13,489 (81)5,891 (86)2,208 (86)554 (84)436 (82)375 (88)188 (91)<0.001
Quality measures
 Patients with atrial fibrillation discharged on anticoagulation5,128 (71)3,713 (71)1,739 (74)289 (68)82 (65)103 (75)65 (86)8 (100)0.003
 Patients with LVSD discharged on aldosterone antagonist2,650 (31)2,034 (32)909 (41)747 (4)128 (37)96 (43)149 (51)93 (58)<0.001
 Black patients with LVSD discharged on hydralazine/nitrate887 (23)388 (20)176 (25)199 (22)14 (16)22 (29)18 (20)18 (16)0.011
 DVT prophylaxis4,589 (71)3,166 (71)1,524 (74)371 (73)132 (76)86 (68)55 (60)28 (67)0.01
 Influenza vaccine during flu season4,947 (40)2,862 (37)1,434 (47)389 (35)123 (42)110 (44)66 (31)25 (29)<0.001
 Pneumococcal vaccination9,380 (39)5,294 (36)2,847 (47)738 (32)226 (40)178 (38)110 (28)39 (21)<0.001

Values are n (%).

Abbreviations as in Table 3.